New funding for S.F. digital pharmacy firm sends its valuation to $1 billion

SoftBank’s Vision II Fund has led a Series D round for San Francisco delivery pharmacy Alto Pharmacy, vaulting its valuation over $1 billion unicorn mark, Reuters reported Thursday based on information from people familiar with the deal and from Delaware State filings. SoftBank’s Vision Fund II contributed around $250 million, according to Reuters, and other investors including Greenoaks Capital and Jackson Square Ventures also participated. Digital pharmacy companies like Alto are gaining…

Click to view original post